Literature DB >> 7852593

Comparison of goat and horse blood as culture medium supplements for isolation and identification of Haemophilus influenzae and Streptococcus pneumoniae from upper respiratory tract secretions.

M Gratten1, D Battistutta, P Torzillo, J Dixon, K Manning.   

Abstract

The results of this study show that goat blood as a culture medium supplement is as supportive as horse blood for the isolation and identification of Haemophilus influenzae and Streptococcus pneumoniae from clinical material. Care is required in the preparation of goat blood chocolate agar to ensure that a thermolabile growth inhibitor of NAD-dependent Haemophilus species is eliminated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7852593      PMCID: PMC264181          DOI: 10.1128/jcm.32.11.2871-2872.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Goat blood agar. Inexpensive media for culturing common bacterial pathogens.

Authors:  F M Feinsod; C H Kim
Journal:  Trop Doct       Date:  1986-07       Impact factor: 0.731

2.  Etiology of severe pneumonia in children in developing countries.

Authors:  F Shann
Journal:  Pediatr Infect Dis       Date:  1986 Mar-Apr

3.  Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan.

Authors:  T D Mastro; A Ghafoor; N K Nomani; Z Ishaq; F Anwar; D M Granoff; J S Spika; C Thornsberry; R R Facklam
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

4.  Multiple colonization of the upper respiratory tract of Papua New Guinea children with Haemophilus influenzae and Streptococcus pneumoniae.

Authors:  M Gratten; J Montgomery; G Gerega; H Gratten; H Siwi; A Poli; G Koki
Journal:  Southeast Asian J Trop Med Public Health       Date:  1989-12       Impact factor: 0.267

5.  Nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide phosphate splitting enzyme(s) of sheep and rabbit erythrocytes: their effect on the growth of Haemophilus.

Authors:  M Artman; G Frankl
Journal:  Can J Microbiol       Date:  1982-06       Impact factor: 2.419

6.  Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance.

Authors:  T D Mastro; N K Nomani; Z Ishaq; A Ghafoor; N F Shaukat; E Esko; M Leinonen; J Henrichsen; R F Breiman; B Schwartz
Journal:  Pediatr Infect Dis J       Date:  1993-10       Impact factor: 2.129

7.  Colonisation of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage, and relationship to carriage in mothers.

Authors:  M Gratten; H Gratten; A Poli; E Carrad; M Raymer; G Koki
Journal:  Biol Neonate       Date:  1986
  7 in total
  4 in total

1.  Pig and goat blood as substitutes for sheep blood in blood-supplemented agar media.

Authors:  C Anand; R Gordon; H Shaw; K Fonseca; M Olsen
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Comparison of citrated human blood, citrated sheep blood, and defibrinated sheep blood Mueller-Hinton agar preparations for antimicrobial susceptibility testing of Streptococcus pneumoniae isolates.

Authors:  Catherine Satzke; Anna Seduadua; Reginald Chandra; Jonathan R Carapetis; E Kim Mulholland; Fiona M Russell
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

3.  As a bacterial culture medium, citrated sheep blood agar is a practical alternative to citrated human blood agar in laboratories of developing countries.

Authors:  F M Russell; S S N Biribo; G Selvaraj; F Oppedisano; S Warren; A Seduadua; E K Mulholland; J R Carapetis
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

4.  Hair sheep blood, citrated or defibrinated, fulfills all requirements of blood agar for diagnostic microbiology laboratory tests.

Authors:  Ellen Yeh; Benjamin A Pinsky; Niaz Banaei; Ellen Jo Baron
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.